Length of postoperative hospital stay · patients undergoing surgery for head and neck cancer
Immunonutrition showed no clear difference in postoperative length of hospital stay (days) compared with standard care (low certainty).
1 finding from 1 review
Wound infection · patients undergoing surgery for head and neck cancer
It is very uncertain whether immunonutrition changes wound infection compared with standard care (very low certainty).
1 finding from 1 review
Fistula formation · patients undergoing surgery for head and neck cancer
Immunonutrition may leads to lower fistula formation compared with standard care (low certainty).
1 finding from 1 review
Adverse events/tolerance of feeds · patients undergoing surgery for head and neck cancer
It is very uncertain whether immunonutrition changes adverse events/tolerance of feeds compared with standard care (very low certainty).
1 finding from 1 review
All‐cause mortality · patients undergoing surgery for head and neck cancer
Immunonutrition showed no clear difference in all‐cause mortality compared with standard care (low certainty).
1 finding from 1 review
Complications
Immunonutrition showed no clear difference in complications compared with standard nutritional supplements (low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
All‐cause mortality
Immunonutrition may leads to lower mortality compared with standard nutritional supplements (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Immunonutrition may leads to lower all‐cause mortality compared with control (low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
Immunonutrition showed no clear difference in systemic inflammatory response syndrome compared with control (low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
Immunonutrition showed no clear difference in organ failure compared with control (low certainty).
1 finding from 1 review
Adverse events · patients with acute pancreatitis
It is very uncertain whether immunonutrition changes adverse events compared with control (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review
Systemic inflammatory response syndrome ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Organ failure ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality within the longest · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
Omega‐3 fatty acids and antioxidants showed no clear difference in all‐cause mortality (longest period reported) compared with placebo or standard nutrition (low certainty).
1 finding from 1 review
Duration of ICU stay · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
1 finding from 1 review
Days on ventilator · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
1 finding from 1 review
Indices of oxygenation (measured as PaO₂/FiO₂ ratio at day 4) · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
1 finding from 1 review